StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca right-of-use lease assets ($M) ($M)

Consolidated Statement of Financial Position (Postgres DB)

Latest, FY2025
1,741
Period ended Dec 31, 2025
Change on a year earlier
+24.8%
1,395 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRight-of-use lease assets ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,741+24.8%Form 20-F (filed 2026-02-24) ↗
FY2024Dec 31, 20241,395+26.8%Form 20-F (filed 2025-02-18) ↗
FY2023Dec 31, 20231,100+16.8%Form 20-F (filed 2024-02-20) ↗
FY2022Dec 31, 2022942-4.7%Form 20-F (filed 2023-02-21) ↗
FY2021Dec 31, 2021988+48.3%Form 20-F (filed 2022-02-22) ↗
FY2020Dec 31, 2020666+2.9%Form 20-F (filed 2021-02-16) ↗
FY2019Dec 31, 2019647-10.4%Form 20-F (filed 2020-03-03) ↗
FY2018Dec 31, 2018722–Form 20-F (filed 2021-02-16) ↗

Cite this data

StockData. (2026). AstraZeneca Right-of-use lease assets ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_rou

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.